Embryonic Stem Cell Research - Update
In January 2007, I wrote about how the House of Representatives was attempting to appropriate funds for embryonic stem cell research and that if it was managed by Big Pharma, such an enterprise would have been shut for lack of return on investment. It has happened!
The latest news on Zenit reports that an embryonic stem cell company located in Singapore has closed down because of lack of confidence among the investors that there will not be any returns soon. The same article states that there is more progress shown in other non-embryonic stem cell research.
In a way this is good news for the babies that could have been aborted and whose stem cells would have been used in this facility. We pray that more such establishments would come to realize that it makes poor business sense to continue such a venture.
